LIVE

/Champion's Path/Alcremie VMAX

Variants

MARGINAL · Conviction 3/10

Alcremie VMAX

Champion's Path · #23 · Rare Holo VMAX

Graded

PSA 9€16.61

PSA 10€31.48

Composite

3.4

Verify externally — possibly staleEU 22% below US

Buy range€2.84 – €3.71Good buy

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

3.4

SCORE / 10

Liquidity

10.0

Scarcity

6.3

Era potential

6.7

Friction

7.6

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 79.29%Total population

PSA 10

3,710

PSA 9

865

PSA 8

Total graded

4,679

Gem rate 79.29%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Champion's Path's Alcremie VMAX (#23) currently trades at €3.40 in the raw market. Its 30-day price movement has declined (-7.9%). By market value it ranks #6 of 80 in Champion's Path — the 95th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated high. Read together, a top-tier ranking in Champion's Path alongside softening 30-day momentum frames where Alcremie VMAX sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.